The eucaLimus Sirolimus Eluting Coronary Stent System convinces with its trusted Cobalt Chromium Platform and the largest size portfolio available.
A fully biodegradable polymer coating containing Sirolimus (Rapamycin), enables controlled drug release preventing early thrombotic events and stent restenosis.
The biocompatible PLGA Polymer provides consistent, controlled and a 100 % drug release. The Polymer degrades 100 % into carbon dioxide and water.